Israel Englander Neuro Bo Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.4 - $0.9 $9,622 - $21,650	24,056 New	24,056 $11,000
Q3 2021 Nov 15, 2021	SELL	$2.73 - $4.52 $80,742 - $133,683	-29,576 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.74 - $4.63 $81,038 - $136,936	29,576 New	29,576 $98,000
Q1 2021 May 17, 2021	SELL	$3.93 - $6.68 $137,498 - $233,713	-34,987 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.02 - $6.59 $163,797 - $215,025	-32,629 Reduced 48.26%	34,987 $184,000
Q3 2020 Nov 16, 2020	SELL	$5.41 - $8.67 $212,645 - $340,783	-39,306 Reduced 36.76%	67,616 $380,000
Q2 2020 Aug 14, 2020	BUY	$8.05 - $29.44 $44,307 - $162,037	5,504 Added 5.43%	106,922 $861,000
Q1 2020 May 14, 2020	BUY	$7.24 - $30.0 $734,266 - $3.04 Million	101,418 New	101,418 $1.3 Million

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.